IL-17 can be protective or deleterious in murine pneumococcal pneumonia.

Streptococcus pneumoniae is the major bacterial cause of community-acquired pneumonia, and the leading agent of childhood pneumonia deaths worldwide. Nasal colonization is an essential step prior to infection. The cytokine IL-17 protects against such colonization and vaccines that enhance IL-17 resp...

Full description

Saved in:
Bibliographic Details
Main Authors: Neil D Ritchie, Ryan Ritchie, Hannah K Bayes, Tim J Mitchell, Tom J Evans
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-05-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007099&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850078761396994048
author Neil D Ritchie
Ryan Ritchie
Hannah K Bayes
Tim J Mitchell
Tom J Evans
author_facet Neil D Ritchie
Ryan Ritchie
Hannah K Bayes
Tim J Mitchell
Tom J Evans
author_sort Neil D Ritchie
collection DOAJ
description Streptococcus pneumoniae is the major bacterial cause of community-acquired pneumonia, and the leading agent of childhood pneumonia deaths worldwide. Nasal colonization is an essential step prior to infection. The cytokine IL-17 protects against such colonization and vaccines that enhance IL-17 responses to pneumococcal colonization are being developed. The role of IL-17 in host defence against pneumonia is not known. To address this issue, we have utilized a murine model of pneumococcal pneumonia in which the gene for the IL-17 cytokine family receptor, Il17ra, has been inactivated. Using this model, we show that IL-17 produced predominantly from γδ T cells protects mice against death from the invasive TIGR4 strain (serotype 4) which expresses a relatively thin capsule. However, in pneumonia produced by two heavily encapsulated strains with low invasive potential (serotypes 3 and 6B), IL-17 significantly enhanced mortality. Neutrophil uptake and killing of the serotype 3 strain was significantly impaired compared to the serotype 4 strain and depletion of neutrophils with antibody enhanced survival of mice infected with the highly encapsulated SRL1 strain. These data strongly suggest that IL-17 mediated neutrophil recruitment to the lungs clears infection from the invasive TIGR4 strain but that lung neutrophils exacerbate disease caused by the highly encapsulated pneumococcal strains. Thus, whilst augmenting IL-17 immune responses against pneumococci may decrease nasal colonization, this may worsen outcome during pneumonia caused by some strains.
format Article
id doaj-art-d887aee2d75345ebb00c2045e965f82e
institution DOAJ
issn 1553-7366
1553-7374
language English
publishDate 2018-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-d887aee2d75345ebb00c2045e965f82e2025-08-20T02:45:28ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742018-05-01145e100709910.1371/journal.ppat.1007099IL-17 can be protective or deleterious in murine pneumococcal pneumonia.Neil D RitchieRyan RitchieHannah K BayesTim J MitchellTom J EvansStreptococcus pneumoniae is the major bacterial cause of community-acquired pneumonia, and the leading agent of childhood pneumonia deaths worldwide. Nasal colonization is an essential step prior to infection. The cytokine IL-17 protects against such colonization and vaccines that enhance IL-17 responses to pneumococcal colonization are being developed. The role of IL-17 in host defence against pneumonia is not known. To address this issue, we have utilized a murine model of pneumococcal pneumonia in which the gene for the IL-17 cytokine family receptor, Il17ra, has been inactivated. Using this model, we show that IL-17 produced predominantly from γδ T cells protects mice against death from the invasive TIGR4 strain (serotype 4) which expresses a relatively thin capsule. However, in pneumonia produced by two heavily encapsulated strains with low invasive potential (serotypes 3 and 6B), IL-17 significantly enhanced mortality. Neutrophil uptake and killing of the serotype 3 strain was significantly impaired compared to the serotype 4 strain and depletion of neutrophils with antibody enhanced survival of mice infected with the highly encapsulated SRL1 strain. These data strongly suggest that IL-17 mediated neutrophil recruitment to the lungs clears infection from the invasive TIGR4 strain but that lung neutrophils exacerbate disease caused by the highly encapsulated pneumococcal strains. Thus, whilst augmenting IL-17 immune responses against pneumococci may decrease nasal colonization, this may worsen outcome during pneumonia caused by some strains.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007099&type=printable
spellingShingle Neil D Ritchie
Ryan Ritchie
Hannah K Bayes
Tim J Mitchell
Tom J Evans
IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
PLoS Pathogens
title IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
title_full IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
title_fullStr IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
title_full_unstemmed IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
title_short IL-17 can be protective or deleterious in murine pneumococcal pneumonia.
title_sort il 17 can be protective or deleterious in murine pneumococcal pneumonia
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1007099&type=printable
work_keys_str_mv AT neildritchie il17canbeprotectiveordeleteriousinmurinepneumococcalpneumonia
AT ryanritchie il17canbeprotectiveordeleteriousinmurinepneumococcalpneumonia
AT hannahkbayes il17canbeprotectiveordeleteriousinmurinepneumococcalpneumonia
AT timjmitchell il17canbeprotectiveordeleteriousinmurinepneumococcalpneumonia
AT tomjevans il17canbeprotectiveordeleteriousinmurinepneumococcalpneumonia